Grateful to have benefited from two impactful NationalCancerGrid initiatives during my oncology residency - EQuIP2023 and CReDO, both of which shaped my approach to quality and research. Thank you Pramesh CS Sir and team🙏

Unique opportunity to hone your knowledge & skills in cancer research methods - last date to apply for the CReDO 15th Jul 2025 Organized by NationalCancerGrid Details at credo.ncgindia.org Apply at credo.ncgindia.org/apply (1/2)

Good to see more and more work on FT of cancer. Here is a list of solutions at different levels that we discovered in our qualitative study on addressing FT - researchsquare.com/article/rs-694…

Thankful to Prof. Raymond Chan Professor Ray Chan for his generous insights during the mentorship session after my oral proffered paper at #MASCC25 His global perspective on 💰 financial toxicity in cancer care is a must-read 📖👇 📄 JCO Oncology Practice: doi.org/10.1200/OP.24.…

📢25 Posts Not To Miss From MASCC 2025 MASCC Ian Kleckner PhD MPH (he/him) | Darcy Burbage, DNP, RN, AOCN | Dr. Kelly Shanahan | Stacey Tinianov (she/her) MPH, BCPA | Dr Rahul Kumar, MD | Praveen Kumar Marimuthu | Chad Han, AdvAPD, PhD | Quinton Ng, PhD | Fumiko Ladd Chino, MD, FASCO | Helsinn Group | Jordan Curry, PhD | Nicolas Hart | Nihanthy Sreenath | Alessandro Villa, DDS, PhD, MPH

💸 Why Financial Toxicity (#FinTox) matters in cancer care Key insights from Dr Fumiko Ladd Chino, MD, FASCO’s excellent plenary at #MASCC25 : 🔻 It erodes quality of life and social functioning 📉 Leads to borrowing, reduced spending on basics and leisure; the burden worsens over time 💥

authors.elsevier.com/a/1lPta1Hx52Nr… Our experience in very advanced LAHNSCC .. there is probably a role of intensified local treatment in exceptional responders..we need prospective randomised trials Tata Memorial Hospital NationalCancerGrid Vanita Noronha, MBBS MD DM sarbani ghosh-laskar Praveen Kumar Marimuthu Josh Thomas Georgy CancerCare

Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts doi.org/10.1016/j.lung… ALKPositiveIndia Together4Cancer Lung Connect India #lcsm

Excellent paper by Sumeet Mirgh MD, DM et al Financial toxicity can be cut to 1% by replacing plerixafor with cyclophosphamide ± bortezomib And keeping the transplant outcomes similar! Practice changing, definitely! 𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM Prashant Mehta Nico Gagelmann

Response-Adapted Surgical & RT de-escalation in Resectable Cutaneous Sq Cell Ca 💡 Neoadj pembro (n=27) : stage II-IV (M0) ✅ cpCR (cCR+pCR) in 63% (95% CI, 42–80) ✅ Total de-escalation (no Sx/RT) in 48% ✅ 0 recurrences at 18 mo in cpCR group doi.org/10.1200/JCO-25… Journal of Clinical Oncology

🚨 New modeling study shows LDCT is a cost-effective lung cancer screening strategy in India In high-risk adults (30–65 yrs), LDCT outperformed Chest X-Ray (CXR) and no screening: 🔹 QALYs: LDCT 23.7 vs CXR 19.8 vs No screening 13.4 🔹 ICER: ₹36,429 (below WTP threshold) 🔹

A new Journal of Clinical Oncology report calls for a paradigm shift in how cancer drug dosages are determined, concluding that the long-standing practice of using the "maximum tolerated dose" may be outdated, harmful to patients, ill-suited for modern cancer therapies ➡️ brnw.ch/21wUp7x

How do oncologists change their treatment based on a patient's financial background? How can we address the financial toxicity of cancer care in India? Read our latest paper to find the answers to these Qs! Association for Socially Applicable Research Pramesh CS Professor Dhananjaya Sharma authors.elsevier.com/a/1lbf37tJEDZl…

Truly humbled to see our essay featured in Spotlight on the Art of Global Oncology JCO Global Oncology Dr Sameer Rastogi A soldier’s sarcoma journey-an inspiring story of courage, hope and the unifying spirit of global oncology. Deeply grateful for your support and encouragement Katherine Van Loon, MD, MPH

📢Our new paper CMC Vellore (Official) Pathology, MedOnc out in ecancer doi.org/10.3332/ecance… After Dr. Dr Ullas Batra's report, this is largest Indian series of tepotinib-Rxed METex14 mNSCLC. Led by Ashish Singh, Dr. Rekha Pai Anjana Joel, Dr. Rohini Ajoy Oommen John Dr. Deepa Susan #LCSM

🙏 Grateful to Department of Health Research, MoHFW ICMR for DIAMOnDS (diamonds.ncdirindia.org)- zonal molecular oncopathology labs, offering free-of-cost advanced molecular diagnostics, expanding equitable access nationwide. Our Pathology Dept CMC Vellore (Official) is part of this initiative.